Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, pla (Q46626206)
Jump to navigation
Jump to search
scientific article published on 29 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, pla |
scientific article published on 29 August 2016 |
Statements
1 reference
Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, pla (English)
1 reference
1 reference
P Vuylsteke
1 reference
M Huizing
1 reference
K Petrakova
1 reference
R Roylance
1 reference
R Laing
1 reference
F Abell
1 reference
S Gendreau
1 reference
I Rooney
1 reference
D Apt
1 reference
J Zhou
1 reference
S Singel
1 reference
L Fehrenbacher
1 reference
29 August 2016
1 reference
1 reference
27
1 reference
11
1 reference
2059-2066
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference